成年患者患有炎症性肠病的细胞巨乳病毒结肠炎
1Government Medical College and Hospital, Chandigarh 160047, India.
Viruses
|June 27, 2025
概括
细胞巨乳病毒 (CMV) 大肠炎复杂化了炎症性肠病 (IBD) 的管理,特别是性大肠炎 (UC). 通过活检和量身定制的抗病毒疗法进行早期诊断,可以改善CMV重新激活IBD患者的治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 细胞巨乳病毒 (CMV) 大肠炎是炎症性肠病 (IBD) 患者,特别是性大肠炎 (UC) 患者的重大并发症.
- 在IBD中,CMV的重新激活与慢性炎症,免疫功能障碍和免疫抑制疗法有关,由于症状与IBD爆发重叠,这给诊断和治疗带来了挑战.
- 肺炎病毒再激活的危险因素包括年龄,胰腺炎和疾病严重程度.
研究的目的:
- 对IBD患者中CMV大肠炎的诊断和治疗挑战进行审查.
- 突出CMV大肠炎对IBD预后和患者结局的影响.
- 讨论在IBD中管理CMV的当前和必要的策略.
主要方法:
- 对包括内镜,组织学,免疫组织化学和定量PCR在内的诊断方式的审查.
- 分析涉及抗病毒疗法 (甘西克洛维尔),皮质类固醇逐渐减少和生物药物的优化 (如Infliximab) 的治疗策略.
- 评估与IBD中CMV结肠炎相关的风险因素和临床结果.
主要成果:
- 诊断依赖于内镜和组织学发现,活检和免疫组织化学是黄金标准.
- 冠状病毒性结肠炎加剧IBD症状,增加住院时间,并提高结肠切除率.
- 抗病毒疗法,特别是甘西克洛维尔,在皮质类固醇耐药性UC患者中显示出改善的结果.
结论:
- 冠状病毒结肠炎显著影响IBD预后,需要早期识别和个性化管理.
- 治疗需要多方面的方法,包括抗病毒疗法,调整免疫抑制和优化IBD特异性治疗.
- 进一步的研究对于完善IBD中CMV的诊断标准和治疗方案至关重要.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
342
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
342
01:30Inflammatory Bowel Disease II: Crohn's Disease
399
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
399
01:29Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
01:29Drugs for Treatment of Ulcerative Colitis in IBD
243
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
243
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
277
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
277
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430